We are live on
!
Find out more
AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
1-Year Est. Return
31.17%
This Fund
S&P 500
This Quarter
Est. Return
+40.05%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
+$50M
(+93%)
Cap. Flow
+$41.5M
Cap. Flow
% of AUM
40%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
4
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Annexon
ANNX
|
+$13.3M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$12.7M |
| 3 |
WHWK
Whitehawk Therapeutics
WHWK
|
+$12.1M |
| 4 |
American Well
AMWL
|
+$3.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CCP
AFA
MCC
SGL
MC
OAM
IP
JCP
Alerce Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, Alerce Investment Management held 7 positions worth $104M, up 93% from $53.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Alerce Investment Management deployed $41.5M of net new capital in Q3 2022, adding to 4 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Alerce Investment Management added most to Annexon in Q3 2022, an estimated $13.3M increase.
- Alerce Investment Management's ten largest holdings make up 100% of its $104M portfolio in Q3 2022.
- Alerce Investment Management opened 0 new positions and closed 0 in Q3 2022.
- Alerce Investment Management's portfolio value rose 93% quarter-over-quarter to $104M.
Based on Alerce Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.